• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将硼分布变化纳入基于微剂量动力学模型的相对生物效应计算,用于硼中子俘获治疗。

Incorporating boron distribution variations in microdosimetric kinetic model-based relative biological effectiveness calculations for boron neutron capture therapy.

机构信息

Department of Nuclear Science and Technology, Nanjing University of Aeronautics and Astronautics, Nanjing, 211106, China.

Joint International Research Laboratory on Advanced Particle Therapy, Nanjing University of Aeronautics and Astronautics, Nanjing, 211100, China.

出版信息

Radiat Prot Dosimetry. 2024 Sep 10;200(14):1319-1328. doi: 10.1093/rpd/ncae158.

DOI:10.1093/rpd/ncae158
PMID:39010755
Abstract

This study introduces the MKM_B model, an approach derived from the MKM model, designed to evaluate the biological effectiveness of Boron Neutron Capture Therapy (BNCT) in the face of challenges from varying microscopic boron distributions. The model introduces a boron compensation factor, allowing for the assessment of compound Biological Effectiveness (CBE) values for different boron distributions. Utilizing the TOPAS simulation platform, the lineal energy spectrum of particles in BNCT was simulated, and the sensitivity of the MKM_B model to parameter variations and the influence of cell size on the model were thoroughly investigated. The CBE values for 10B-boronphenylalanine (BPA) and 10B-sodium (BSH) were determined to be 3.70 and 1.75, respectively. These calculations were based on using the nucleus radius of 2.5 μm and the cell radius of 5 μm while considering a 50% surviving fraction. It was observed that as cell size decreased, the CBE values for both BPA and BSH increased. Additionally, the model parameter rd was identified as having the most significant impact on CBE, with other parameters showing moderate effects. The development of the MKM_B model enables the accurate prediction of CBE under different boron distributions in BNCT. This model offers a promising approach to optimize treatment planning by providing increased accuracy in biological effectiveness.

摘要

本研究介绍了 MKM_B 模型,该模型源自 MKM 模型,旨在评估硼中子俘获治疗(BNCT)在面对不同微观硼分布挑战时的生物学有效性。该模型引入了硼补偿因子,允许评估不同硼分布的复合生物学有效性(CBE)值。利用 TOPAS 模拟平台,模拟了 BNCT 中粒子的线性能量谱,并彻底研究了 MKM_B 模型对参数变化的敏感性以及细胞大小对模型的影响。确定 10B-硼苯丙氨酸(BPA)和 10B-硼酸钠(BSH)的 CBE 值分别为 3.70 和 1.75。这些计算是基于使用 2.5μm 的核半径和 5μm 的细胞半径,同时考虑 50%的存活分数。结果表明,随着细胞尺寸的减小,BPA 和 BSH 的 CBE 值均增加。此外,模型参数 rd 被确定对 CBE 具有最大影响,其他参数的影响适中。MKM_B 模型的开发使得能够在 BNCT 中不同硼分布下准确预测 CBE。该模型为通过提供更高的生物学有效性准确性来优化治疗计划提供了一种有前途的方法。

相似文献

1
Incorporating boron distribution variations in microdosimetric kinetic model-based relative biological effectiveness calculations for boron neutron capture therapy.将硼分布变化纳入基于微剂量动力学模型的相对生物效应计算,用于硼中子俘获治疗。
Radiat Prot Dosimetry. 2024 Sep 10;200(14):1319-1328. doi: 10.1093/rpd/ncae158.
2
Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.大鼠皮肤对用对硼苯丙氨酸或硼卡醇钠进行硼中子俘获治疗的反应。
Radiother Oncol. 1994 Aug;32(2):144-53. doi: 10.1016/0167-8140(94)90101-5.
3
Microdosimetric Modeling of Biological Effectiveness for Boron Neutron Capture Therapy Considering Intra- and Intercellular Heterogeneity in B Distribution.考虑硼中子俘获治疗中硼分布的细胞内和细胞间异质性的生物效应用微剂量学建模。
Sci Rep. 2018 Jan 17;8(1):988. doi: 10.1038/s41598-017-18871-0.
4
Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.基于加速器的硼中子俘获治疗恶性脑胶质瘤:使用硼苯丙氨酸、硼替佐米和脂质体硼替佐米对 SCID 小鼠异位 U87 脑胶质瘤模型进行的中子辐照初步研究。
Int J Radiat Biol. 2020 Jul;96(7):868-878. doi: 10.1080/09553002.2020.1761039. Epub 2020 May 12.
5
Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.硼中子俘获疗法对原发性和转移性黑色素瘤细胞系的生物学有效性评估。
Int J Radiat Biol. 2015 Jan;91(1):81-9. doi: 10.3109/09553002.2014.942013. Epub 2014 Aug 11.
6
Primary study of the relative and compound biological effectiveness model for boron neutron capture therapy based on nanodosimetry.基于纳米剂量学的硼中子俘获治疗相对和复合生物效应模型的初步研究。
Med Phys. 2024 Apr;51(4):3076-3092. doi: 10.1002/mp.16998. Epub 2024 Feb 26.
7
Response of the central nervous system to boron neutron capture irradiation: evaluation using rat spinal cord model.中枢神经系统对硼中子俘获辐照的反应:使用大鼠脊髓模型进行评估
Radiother Oncol. 1994 Sep;32(3):249-55. doi: 10.1016/0167-8140(94)90024-8.
8
Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.硼在口腔黏膜组织中的微观定位:对硼中子俘获疗法的启示。
Br J Cancer. 2000 Jun;82(11):1764-71. doi: 10.1054/bjoc.2000.1148.
9
A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.硼中子俘获治疗后人黑色素瘤细胞杀伤的剂量率效应估算模型。
Cells. 2020 Apr 30;9(5):1117. doi: 10.3390/cells9051117.
10
Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.使用硼苯丙氨酸和硼卡醇钠将硼(10)递送至口腔鳞状细胞癌用于硼中子俘获治疗。
Oral Oncol. 2004 May;40(5):474-82. doi: 10.1016/j.oraloncology.2003.09.018.